申请人:Barrett D. Stephen
公开号:US20050004186A1
公开(公告)日:2005-01-06
This invention provides substituted Phenyl-(2-[1,3,4]thiadiazol-2-yl-phenyl)-amine and (2-[1,3,4]Oxadiazol-2-yl-phenyl)phenyl-amine compounds which act as inhibitors of MAPK/ERK Kinase (“MEK”) enzymes and pharmaceutical compositions and methods for their use in immunomodulation and in the treatment and alleviation of inflammation, and proliferative diseases such as cancer and restenosis.
本发明提供了取代苯基-(2-[1,3,4]噻二唑-2-基苯基)-胺和(2-[1,3,4]噁二唑-2-基苯基)苯基胺化合物,其作为MAPK/ERK激酶(“MEK”)酶的抑制剂,并提供了在免疫调节和治疗和缓解炎症、癌症和再狭窄等增殖性疾病中使用它们的制药组合物和方法。